The Egyptian Journal of Otolaryngology

Table 1 Patients’ features

From: Early detection of cochlear hearing loss in rheumatoid arthritis patients: a cross-sectional study

			Cases n=50
Age		Mean ± SD	40.1	±5.3
Duration		Median (minimum–maximum)	8	2–20
RF	Negative	N, %	27	54%
RF	positive	N, %	23	46%
ACCP	Negative	N, %	12	24%
ACCP	positive	N, %	38	76%
DAS	Remission	N, %	28	56%
DAS	Active	N, %	22	44%
PTA	Normal	N, %	41	82%
	Mild	N, %	7	14%
	Moderate	N, %	2	4%
EHFA	Normal	N, %	11	22%
	Mild	N, %	15	30%
	Moderate	N, %	10	20%
	Moderately severe	N, %	8	16%
	Severe	N, %	6	12%
Tympanometry	Type A	N, %	50	100%
AR	Present	N, %	26	52%
AR	NR	N, %	24	48%
TEOAE	Pass	N, %	27	54%
TEOAE	Refer	N, %	23	46%

RF rheumatoid factor, ACCP anti-cyclic citrullinated peptide, DAS disease activity score, PTA pure tone audiometry, EHFA extended high frequency audiometry, AR acoustic reflex, TEOAEs transient evoked oto-acoustic emission, NR no response, SD standard deviation

Back to article page